Tony Ho
Tony Ho is a Senior Science Partner at Pivotal Life Sciences. He previously held leadership roles at Crispr Therapeutics, AstraZeneca, and Merck.
What Tony can write
Pivotal bioVenture Partners writes $3M to $30M checks, larger than 93% of firms in the atlas.
Bars: how many firms report each check band. Highlighted: Pivotal bioVenture Partners.Career
- Neuronyx · CSO
- Merck · head of Neurology and Ophthalmology
- AstraZeneca · SVP and Head of Oncology Integration and Innovation
- Crispr Therapeutics · Executive Vice President, Head of Research and Development
- Pivotal Life Sciences · Senior Science Partner
- Pivotal bioVenture Partners · Senior Science PartnerNow
Companies founded
Focus
Education
Also at Pivotal bioVenture Partners
Partners like Tony
At firms with a similar stage, sector and check size.
Alert me when Pivotal bioVenture Partners is active
One email when Tony's firm raises a fund, adds a partner or shows new activity.
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckQuestions
Who is Tony Ho?
Tony Ho is a Senior Science Partner at Pivotal Life Sciences. He previously held leadership roles at Crispr Therapeutics, AstraZeneca, and Merck.
How much does Tony Ho invest?
Tony Ho invests through Pivotal bioVenture Partners, which writes checks of $3M to $30M at pre-seed, seed, series a, series b.
How do I pitch Tony Ho?
A warm intro from a founder Pivotal bioVenture Partners backed works best. A short LinkedIn note with one line on traction is the next best route.
What did Tony Ho do before Pivotal bioVenture Partners?
CSO at Neuronyx; head of Neurology and Ophthalmology at Merck; SVP and Head of Oncology Integration and Innovation at AstraZeneca; Executive Vice President, Head of Research and Development at Crispr Therapeutics; Senior Science Partner at Pivotal Life Sciences.
Last updated 2026-10-15. Is this you? Ask for a correction.